Plamen Angelov

Marketing Manager Biosimilars for CEE at Alvogen
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
BG

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • United States
    • Pharmaceutical Manufacturing
    • 300 - 400 Employee
    • Marketing Manager Biosimilars for CEE
      • Jul 2013 - Present

      - Marketing of biosimilar filgrastim (Nivestim), epoetin alfa (Retacrit) and infliximab (Inflectra) in partnership with Hospira, a Pfizer Company - Launching Inflectra (infliximab, the first biosimilar monoclonal antibody registered by EMA) in Alvogen markets (Europe): • Central and Eastern Europe (CEE): Bulgaria, Croatia, Hungary, Poland, Romania • Baltic states: Estonia, Latvia, Lithuania • West Balkans: Albania, Bosnia and Herzegovina, Kosovo, Macedonia, Montenegro, Serbia • Iceland Show less

    • Marketing Excellence External Consultant
      • Jan 2013 - Jun 2013

      Strategic input on marketing excellence and sales expertise Strategic input on marketing excellence and sales expertise

    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Medical Advisor Immunology
      • Jan 2012 - Dec 2012

      - Scientific information management- Identify and liaise with outside experts and opinion leaders- Deliver medical information and training to marketing and sales persons - rheumatology, gastroenterology and dermatology fields

    • Product Manager Humira
      • Jan 2011 - Dec 2011

      Developing Humira marketing strategy and implementation tactics - all indications

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Product Manager CNS/Psychiatry
      • Jan 2005 - Dec 2010

      Development and execution of country-wide marketing and sales strategy for Risperdal, Risperdal Consta and Invega- Re-launching Risperdal Consta- Launching Invega- Pre-launch of Invega Sustenna (paliperidone palmitate)

    • Key Account Manager
      • Aug 2003 - Dec 2004

      CNS/Psychiatry - Risperdal; Risperdal Consta

    • Medical Representative CNS/Psychiatry
      • Oct 2000 - Jul 2003

      Promotion of Risperdal/Rispolept (both in schizophrenia and bipolar disorder) Promotion of Risperdal/Rispolept (both in schizophrenia and bipolar disorder)

    • United States
    • Pharmaceutical Manufacturing
    • 700 & Above Employee
    • Product Manager
      • Jan 1999 - Sep 2000

      - Marketing allergology and dermatology line- Launching 3 brands

    • Professional Sales Representative
      • Jun 1998 - Dec 1998

      Promotion of allergology (Claritine, Clarinase); dermatology (Elocom, Diprosone, Diprogenta, Diprosalic, Diprophos); ophthalmology (Celestone, Garasone); anti-asthma (Aldecin) and OTC (Afrine) products

Education

  • Sofia Medical Univercity - Pharmaceutical Faculty
    Master of Science (MSc), Pharmaceutical Sciences
    1991 - 1996
  • Romain Rolland Foreign Language School
    1986 - 1991

Community

You need to have a working account to view this content. Click here to join now